Assessing walking function in children with juvenile idiopathic arthritis
Investigation of Validity and Reliability of Dynamic Walking Index in Childhood Rheumatic Diseases
This study is testing a walking assessment tool to see how well it can identify walking problems in children with juvenile idiopathic arthritis.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 52 (estimated) |
| Ages | 8 Years to 16 Years |
| Sex | All |
| Sponsor | Istanbul University - Cerrahpasa Academic / other |
| Locations | 1 site (Istanbul, Turkey) |
| Trial ID | NCT06870045 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the Dynamic Gait Index (DGI) as a functional assessment tool for walking in children diagnosed with juvenile idiopathic arthritis (JIA). The DGI measures various aspects of walking, including speed changes, head turns, and obstacle navigation, to identify gait disorders that may arise from JIA. The study includes children aged 8-16 with unilateral knee involvement and compares their results to a control group without any neurological or orthopedic conditions. By establishing the DGI's effectiveness in this population, the study aims to enhance the understanding of walking difficulties in children with JIA.
Who should consider this trial
Good fit: Ideal candidates are children aged 8-16 with a diagnosis of juvenile idiopathic arthritis and unilateral knee joint involvement.
Not a fit: Patients with additional neurological or orthopedic diagnoses that affect walking may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved assessment and management of walking difficulties in children with juvenile idiopathic arthritis.
How similar studies have performed: While the Dynamic Gait Index is widely used in other populations, its application in children with JIA is novel and has not been previously tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Study Group; * Having a JIA diagnosis according to ILAR criteria between the ages of 8-16, * Having unilateral knee joint involvement that will affect walking * Being compatible, volunteer and cooperative in the study Control Group; 1. Not having any neurological or orthopedic diagnosis 2. Being between the ages of 8-16 3. Being at a mental level that can understand the commands of the person performing the evaluation Exclusion Criteria: * Study Group; * Having an additional neurological or orthopedic diagnosis accompanying JIA and affecting treatment results, * Having lower extremity asymmetry or active lower extremity involvement other than the knee joint that will affect walking. Control Group; -Having any health problem that may affect the study
Where this trial is running
Istanbul, Turkey
- Istanbul University-Cerrahpasa — Istanbul, Turkey, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Gökçe Leblebici, PhD
- Email: leblebicigokce@gmail.com
- Phone: +905397395718
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.